Management of mycetoma

References

• Fahal AH. Mycetoma: Clinico–Pathological Monograph. University of Khartoum Press, Khartoum, Sudan, 59–70 (2006).
   Google Scholar
• Fahal AH. Mycetoma thorn on the flesh. Trans. R. Soc. Trop. Med. Hyg.98(1), 3–11 (2004).
   PubMed Web of Science ®Google Scholar
• Hassan MA, Fahal AH. Mycetoma. In: Tropical Surgery. Kamil R, Lumby J (Eds), Westminster Publications, London, UK, 786–790 (2004).
   Google Scholar
• Ahmed AO, van Leeuwen W, Fahal A et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis.4(9), 566–574 (2004).
   PubMed Web of Science ®Google Scholar
• Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr. Opin. Infect. Dis.20(2), 146–151 (2007).
   PubMed Web of Science ®Google Scholar
• Abd El-Bagi MEB, Fahal AH. Mycetoma revisited. Incidence of various radiographic signs. Saudi Med. J.30(4), 529–533 (2009).
   PubMed Web of Science ®Google Scholar
• Fahal AH, El Toum EA, EL Hassan AM, Gumaa SA, Mahgoub ES. Host tissue reaction to Madurella mycetomatis: new classification. J. Med. Vet. Myco.33, 15–17 (1995).
   PubMedGoogle Scholar
• Fahal AH, Sheikh HE, El Lider MA, Homeida MA, EL Arabi YE, Mahgoub ES. Ultrasonic imaging in mycetoma. Br. J. Surg.78, 765–766 (1997).
   Google Scholar
• Yousif BM, Fahal AH, Yahia MY. The cell block technique: a new diagnostic tool for mycetoma. Trans. R. Soc. Trop. Med. Hyg. (2010) (In Press).
   PubMedGoogle Scholar
• Ahmed AO, Mukhtar MM, Kools-Sijmons M et al. Development of a species-specific PCR RFLP procedure for the identification of Madurella mycetomatis. J. Clin. Microbiol.37(10), 3175–3178 (1999).
   PubMed Web of Science ®Google Scholar
• Bonifaz A, González-Silva A, Albrandt-Salmerón A et.al. Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases. Br. J. Dermatol.158(4), 698–704 (2008).
   PubMed Web of Science ®Google Scholar
• Mahgoub ES. Mycetoma. Semin. Dermatol.4, 230 (1985).
   Google Scholar
• Mahgoub ES. Medical management of mycetoma. Bull. World Health Organ.54(3), 303–310 (1976).
   PubMed Web of Science ®Google Scholar
• Mahgoub ES. Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim. Am. J. Trop. Med. Hyg.21(3), 332–335 (1972).
   PubMed Web of Science ®Google Scholar
• Gomez-Flores A, Welsh O, Said-Fernández S, Lozano-Garza G, Tavarez- Alejandro RE, Vera-Cabrera L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob. Agents Chemother.48(3), 832–837 (2004).
   PubMed Web of Science ®Google Scholar
• Welsh O, Sauceda E, Gonzalez J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J. Am. Acad. Dermatol.17(3), 443–448 (1987).
   PubMed Web of Science ®Google Scholar
• Damle DK, Mahajan PM, Pradhan SN et al. Modified Welsh regimen: a promising therapy for actinomycetoma. J. Drugs Dermatol.7(9), 853–856 (2008).
   PubMedGoogle Scholar
• Vera-Cabrera L, Daw-Garza A, Said-Fernández S et al. Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis. PLoS Negl. Trop. Dis. 10, 2(9), e289 (2008).
   Google Scholar
• Chacon-Moreno BE, Welsh O, Cavazos-Rocha N et al. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensisin vitro and in an experimental model of actinomycetoma in BALB/c mice. Antimicrob. Agents Chemother.53(1), 295–297 (2009).
   PubMed Web of Science ®Google Scholar
• Gomez A, Saul A, Bonifaz A. Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int. J. Dermatol.32(3), 218–220 (1993).
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Flores P, Saúl A, Carrasco-Gerard E, Ponce RM. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin–clavulanate. Br. J. Dermatol.156(2), 308–311 (2007).
   PubMed Web of Science ®Google Scholar
• Fuentes A, Arenas R, Reyes M, Fernández RF, Zacarías R. Actinomycetoma and Nocardia sp. Report of five cases treated with imipenem or imipenem plus amikacin. Gac. Med. Mex.142, 247–252 (2006).
   PubMedGoogle Scholar
• Yazawa K, Mikami Y, Ohashi S, Miyaji M, Ichihara Y, Nishimura C. In vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp. J. Antimicrob. Chemother.29(2), 169–172 (1992).
   PubMed Web of Science ®Google Scholar
• Lai CC, Tan CK, Lin SH et al. Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species. J. Antimicrob. Chemother.64(1), 73–78 (2009).
   PubMed Web of Science ®Google Scholar
• Cercenado E, Marín M, Sánchez-Martínez M, Cuevas O, Martínez-Alarcón J, Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob. Agents Chemother.51(3), 1102–1104 (2007).
   PubMed Web of Science ®Google Scholar
• Espinoza-González NA, Welsh O, de Torres NW et al. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis. Molecules13(1), 31–40 (2008).
   PubMed Web of Science ®Google Scholar
• Ameen M, Arenas R. Emerging therapeutic regimes for the management of mycetomas. Expert Opin. Pharmacother.9(12), 2077–2085 (2008).
   PubMed Web of Science ®Google Scholar
• Ameen M, Arenas R. Developments in the management of mycetomas. Clin. Exp. Dermatol.34(1), 1–7 (2009).
   PubMed Web of Science ®Google Scholar
• Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J. Am. Acad. Dermatol.53, 931–951 (2005).
   PubMed Web of Science ®Google Scholar
• Mahgoub ES, Gumaa SA. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomi. Trans. R. Soc. Trop. Med. Hyg.78, 376 (1984).
   PubMed Web of Science ®Google Scholar
• Ahmed AO, van de Sande WW, van Vianen W et al. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-cotrimoxazole(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob. Agents Chemother.48(7), 2742–2746 (2004).
   PubMed Web of Science ®Google Scholar
• van de Sande WW, Fahal AH, Riley TV, Verbrugh H, van Belkum A. In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J. Antimicrob. Chemother.59(3), 553–555 (2007).
   PubMed Web of Science ®Google Scholar
• van de Sande WW, de Kat J, Coppens J et al. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect.9, 1114–1123 (2007).
   PubMed Web of Science ®Google Scholar
• Badali H, Najafzadeh MJ, Van Esbroeck M et al. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med. Mycol.29, 1–10 (2009).
   Google Scholar
• Al-Tawfiq JA, Amr SS. Madura leg due to Exophiala jeanselmei successfully treated with surgery and itraconazole therapy. Med. Mycol.14, 1–5 (2009).
   Google Scholar
• Konishi M, Yonekawa S, Nakagawa C et al. Case of Scedosporium apiospermum cutaneous soft tissue infection treated with voriconazole. Kansenshogaku Zasshi.82(2), 82–85 (2008).
   PubMedGoogle Scholar
• Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermumand Scedosporium prolificans. Antimicrob. Agents Chemother.52(3), 1136–1139 (2008).
   PubMed Web of Science ®Google Scholar
• Scheinfeld N. A review of the new antifungals: posaconazole, micafungin, and anidulafungin. Drugs Dermatol.6(12), 1249–1251 (2007).
   PubMedGoogle Scholar
• Loo DS. Systemic antifungal agents: an update of established and new therapies. Adv Dermatol.22, 101–124 (2006).
   PubMedGoogle Scholar
• López-Cervantes M, Escobar-Chávez JJ, Casas-Alancaster N et al. Development and characterization of a transdermal patch and an emulgel containing kanamycin intended to be used in the treatment of mycetoma caused by Actinomadura madurae. Drug Dev. Ind. Pharm.35(12), 1511–1521 (2009).
   PubMed Web of Science ®Google Scholar